Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Meerpohl

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Therapeutische Umschau. Revue Therapeutique|December 1, 1989
[Diagnosis and primary treatment of malignant epithelial ovarian tumor]H G Meerpohl
Onkologie|May 1, 1984
[Chemotherapy of advanced epithelial ovarian carcinoma]H G Meerpohl
Onkologie|October 1, 1985
[Prognostic factors of ovarian cancer]H G Meerpohl
Praxis|May 11, 1999
[Paclitaxel/carboplatin in first line treatment of advanced ovarian carcinoma]H G Meerpohl
Prostaglandins|May 1, 1986
Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functionsH G Meerpohl, T Bauknecht
Onkologie|December 1, 1985
[Control of the response of ovarian cancers to cytostatic therapy and the value of the second-look operation]G Teufel, H G Meerpohl, A Pfleiderer
Geburtshilfe Und Frauenheilkunde|October 1, 1996
[Sequential course and prospective management of ifosfamide-induced multi-organ toxicity]A Mollenkopf, A du Bois, H G Meerpohl
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1995
The role of serotonin as a mediator of emesis induced by different stimuliA du Bois, H Kriesinger-Schroeder, H G Meerpohl
Zentralblatt Fur Gynakologie|January 1, 1997
[Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities]A du Bois, H J Lück, H G Meerpohl
Onkologie|October 1, 1982
Chemotherapy for stage III-IV ovarian cancer: the CAP-regimen in previously untreated patientsH G Meerpohl, A Pfleiderer, W Kleine, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Therapeutische Umschau. Revue Therapeutique|December 1, 1989
[Diagnosis and primary treatment of malignant epithelial ovarian tumor]H G Meerpohl
Onkologie|May 1, 1984
[Chemotherapy of advanced epithelial ovarian carcinoma]H G Meerpohl
Onkologie|October 1, 1985
[Prognostic factors of ovarian cancer]H G Meerpohl
Praxis|May 11, 1999
[Paclitaxel/carboplatin in first line treatment of advanced ovarian carcinoma]H G Meerpohl
Prostaglandins|May 1, 1986
Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functionsH G Meerpohl, T Bauknecht
Onkologie|December 1, 1985
[Control of the response of ovarian cancers to cytostatic therapy and the value of the second-look operation]G Teufel, H G Meerpohl, A Pfleiderer
Geburtshilfe Und Frauenheilkunde|October 1, 1996
[Sequential course and prospective management of ifosfamide-induced multi-organ toxicity]A Mollenkopf, A du Bois, H G Meerpohl
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1995
The role of serotonin as a mediator of emesis induced by different stimuliA du Bois, H Kriesinger-Schroeder, H G Meerpohl
Zentralblatt Fur Gynakologie|January 1, 1997
[Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities]A du Bois, H J Lück, H G Meerpohl
Onkologie|October 1, 1982
Chemotherapy for stage III-IV ovarian cancer: the CAP-regimen in previously untreated patientsH G Meerpohl, A Pfleiderer, W Kleine, et al.
Pageof 4